Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/32815
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCrowther, C.en
dc.contributor.authorHenderson-Smart, D.en
dc.date.issued2001en
dc.identifier.citationThe Cochrane Database of Systematic Reviews, 2001; 2001(4):www1-www9en
dc.identifier.issn1469-493Xen
dc.identifier.issn1469-493Xen
dc.identifier.urihttp://hdl.handle.net/2440/32815-
dc.description.abstractBACKGROUND:Preterm infants are at risk of periventricular haemorrhage. This can be a sign of brain damage that might lead to neurodevelopmental abnormalities, including cerebral palsy. It has been suggested that vitamin K might improve coagulation in preterm infants. OBJECTIVES:The objective of this review was to assess the effects of vitamin K administered to women at risk of imminent very preterm birth to prevent periventricular haemorrhage and associated neurological injury in the infant. SEARCH STRATEGY:We searched the Cochrane Pregnancy and Childbirth Group trials register, Cochrane Controlled Trials Register, and bibliographies up to September 2000. SELECTION CRITERIA:Randomised or quasi-randomised trials of vitamin K administered parenterally or orally to women at risk of imminent preterm birth. The primary outcomes were neonatal mortality, neonatal neurological morbidity, as measured by the presence of periventricular haemorrhage (PVH) on ultrasound during the first week of life, and long term neurodevelopment. Secondary outcomes included other neonatal morbidity and any maternal side effects. DATA COLLECTION AND ANALYSIS:Eligibility, trial quality assessment and data extraction were done independently by two reviewers. MAIN RESULTS:Five trials were included, involving more than 420 women. The trials were of variable quality. Antenatal vitamin K was associated with a non-significant trend to a reduction in all grades of periventricular haemorrhage (relative risk (RR) 0.82, 95% confidence interval (CI) 0.67-1.00) and in severe PVH (grades 3 and 4) (RR 0.75, 95% CI 0.45-1.25) for babies receiving prenatal vitamin K compared with control babies. This trend disappeared when poorer quality trials were excluded. Information on neurodevelopment was only given for a small sample of children in one trial with discrepancy in results given in the two reports. REVIEWER'S CONCLUSIONS:Vitamin K administered to women prior to very preterm birth has not been shown to significantly prevent periventricular haemorrhages in preterm infants.en
dc.description.statementofresponsibilityCrowther CA, Henderson-Smart DJen
dc.language.isoenen
dc.publisherUpdate Software Ltden
dc.source.urihttp://www.cochrane.org/reviews/en/ab000229.htmlen
dc.subjectCerebral Ventricles; Humans; Cerebral Hemorrhage; Infant, Premature, Diseases; Vitamin K; Antifibrinolytic Agents; Pregnancy; Infant, Newborn; Female; Obstetric Labor, Premature; Randomized Controlled Trials as Topicen
dc.titleVitamin K prior to preterm birth for preventing neonatal periventricular haemorrhageen
dc.typeJournal articleen
dc.identifier.rmid0020012665en
dc.identifier.doi10.1002/14651858.CD000229en
dc.identifier.pubid60783-
pubs.library.collectionObstetrics and Gynaecology publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidCrowther, C. [0000-0002-9079-4451]en
Appears in Collections:Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.